Thirty PLHIV in Melbourne took part in the randomised, placebo-controlled VIVA trial. Researchers looked to see if 24 weeks of high dose vitamin D3 could reduce the amount of HIV that persists on ART. After 24 weeks, there was no change in HIV DNA. Encouragingly though, there was a reduction in total HIV DNA 12…
Sydney researchers are leading a study to discover more about the HIV reservoir. The TRESAX study seeks to find out where HIV rebounds from during treatment interruption and what impact vaccination has on virus rebound. The work is led by Kirby Institute Director Professor Tony Kelleher and research fellow Dr Mee Ling Munier. The study…
HIV infection takes a heavy toll on the gut. The virus enters the body and heads straight for the stomach and intestines. This is harmful, destroying most of the immune cells that live in the gut. This early damage sets the scene for some of the big problems of ongoing HIV infection. One of these…
Scientists at the Lewis Katz School of Medicine at Temple University in Philadelphia have designed a gene-editing system that may hold the answer for an eventual cure for people living with HIV. The study — published in the Nature journal Scientific Reports — explains how researchers have eradicated the virus from human cell DNA. “The…
Sangamo Biosciences’ efforts to develop genetic therapies for HIV have had some early success, with two of three participants in one cohort maintaining control of the virus for an extended period during which they were not taking standard antiretroviral (ARV) treatment. The biotech company is conducting a Phase I/II study, known as SB-728-1101, of its…
This beautiful photographic essay was compiled by The Alfred in Melbourne, and all credit for this article goes to their amazing teams and the people they care for. This article is shared with permission of The Alfred.
.png)
Working together with researchers and clinicians at The Alfred, members of the community of people living with HIV in Victoria have been integral to progressing ...
